PURPLE BIOTECH LTD's ticker is PPBT and the CUSIP is 74638P109. A total of 15 filers reported holding PURPLE BIOTECH LTD in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $33,000 | -15.4% | 16,454 | 0.0% | 0.00% | -20.0% |
Q2 2022 | $39,000 | -40.0% | 16,454 | 0.0% | 0.01% | -37.5% |
Q1 2022 | $65,000 | +1.6% | 16,454 | 0.0% | 0.01% | +33.3% |
Q4 2021 | $64,000 | -14.7% | 16,454 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $75,000 | -6.2% | 16,454 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $80,000 | +17.6% | 16,454 | 0.0% | 0.01% | +12.5% |
Q1 2021 | $68,000 | +7.9% | 16,454 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $63,000 | – | 16,454 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WASHINGTON TRUST BANK | 16,454 | $39,000 | 0.01% |
Virtu Financial LLC | 13,719 | $33,000 | 0.00% |
Venture Visionary Partners LLC | 13,068 | $31,232,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 27,037 | $65,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 12,666 | $30,000 | 0.00% |
North Star Investment Management Corp. | 300 | $1,000 | 0.00% |
MORGAN STANLEY | 16,770 | $40,000 | 0.00% |
Citadel Advisors | 13,800 | $33,000 | 0.00% |
Citadel Advisors | 11,904 | $28,000 | 0.00% |